Date:   8/3/2012 7:38:42 AM ( 13 y ago)
Hits:   2,281
URL:   https://www.curezone.org/forums/fm.asp?i=1970526

Interesting about lecithin too.

"Can't speak to the niacin but the lecithin (derived from eggs) apparently is there to help your stomach and body to avoid Iodine issues while the Iodine is the active ingredient."

I actually saw the research, posted years ago regarding the below article but only have found the file, which I can’t open. I searched constantly to find anything that will reduce plaque(I did eventually find K2-mk4 also)in my veins:


Over 30 years ago, two ophthalmologists observed that a combination tablet called “Iodo-niacin” (iodide 120 milligrams, niacin 15 milligrams) taken for several months could actually reverse atherosclerotic clogging of arteries. They proved this effect by taking pictures of clogged arteries in the backs of the eyes (“retinal photomicrographs”) before and after treatment. The published photographs showed a significant lessening of the cholesterol-laden artery clogging in the “after” pictures."

Use of iodo-niacin for retinal or vitreous hemorrhages and vitreous floaters.
November 1956 Am J Ophthalmol Vol. 42, Issue 5, Pages 771-2

Use of Iodo-Niacin, Abrahamson, I. A.: American Journal of Ophthalmology 42 (5): 771-772 1956
http://web.archive.org/web/20070908193524/http:/panaminstitute.com/de-iodine.htm


Blog on the subject:
This reminded me of a discussion of niacin Iodine on this forum. Niacin iodine was apparently used through the 1950s and 1960s in the US to treat vitreous hemorrhage as well as cholesterol build up in ocular arteries but fell out of favor as not patentable. Apparently, the iodine makes certain soapy or polar substances more water soluble. So it could work for some garbage implicated in floaters, particularly, blood, possibly proteins.

Can't speak to the niacin but the lecithin (derived from eggs) apparently is there to help your stomach and body to avoid iodine issues while the iodine is the active ingredient. The idea behind iodine being effective is that it both helps dissolve fatty substances and can into vitreous--unlike larger molecules that cannot Here are references for above:

Iodine makes polar substances more soluble. Dr. Wright at Tahoma CLinic quotes Harvard chemistry professor:
http://tahomaclinicblog.com/iodide/


Iodo Niacin dissolves hemorrhage in vitreous. Drs. Abrahamson citation--don't have article

http://www.ncbi.nlm.nih.gov/pubmed/13372702


from article: The use of iodine niacin preparations for the purpose of absorbing intraocular hemorrhages and strengthening damaged vascular walls has been known and used extensively for many years, but for some reason has recently fallen into more or less disrepute. In fact the treatment of recurrent and massive vitreal and retinal hemorrhages and vitreous floaters has been relatively unsatisfactory with the drugs at our disposal. Damrau found that the iodides did prevent artificial arteriosclerosis in rabbits in which it had been produced by high cholesterol feedings. Feinglatt and Ferguson in 1955 reported a series of 59 cases of generalized arteriosclerosis which were treated with Iodo-Niacin in full dosage for over a year with considerable therapeutic benefit and no iodism or adverse effects. In a controlled clinical investigation using comparable group on placebo medication, Iodo-Niacin tablets provided successful results in a series of 22 cases of retinal or vitreous hemorrhages and 89 of vitreous floaters. The tablets contain potassium Iodide 135 mg. and niacinamide hydroiodide 25 mg. The dosage was one tablet three times daily after meals. Iodo-Niacin was administered for periods of one to 13 months to an equal number of males and females between the ages of 18 and 87 years with various ocular conditions. The series included 12 cases of retinal hemorrhages and 89 of vitreous floaters. As compared with the control group, who received the placebo absorption of retinal hemorrhages, in the patients treated with Iodo-Niacin was much more rapid and complete. In a typical case of extensive retinal hemorrhages observed in the arteriosclerosis fundus of a patient with hypertension, Iodo-Niacin produced spectacular absorption in 18 days. In another case of angiospastic hemorrhages and edema involving the macula, substantial improvement was observed ophthalmoscopically after 25 days of treatment with Iodo-Niacin. The results have been recorded by before and after retinal photographs. Results in cases of vitreous hemorrhages were also dramatic. In four postoperative cataract cases, the condition cleared completely in three to four weeks. In a diabetic case which had resisted treatment for two years, the fundus was seen with 20/70 clarity after two months on Iodo-Niacin. Results were satisfactory in five other cases of vitreous hemorrhages due to diabetes or hypertension. Over 90 percent of the 89 patients with vitreous floaters who were treated with Iodo-Niacin showed subjective improvement and 50 percent showed objective improvement. Large vitreous floaters appeared to diminish in size and some of the fine dustlike opacities disappeared entirely. In several cases the vitreous floaters disappeared completely; in others they were reduced in size ophthalmoscopically after treatment with Iodo-Niacin for one to six months.
Niaco Iodine dissolves arteriosclerosis in eye arteries.

http://www.ncbi.nlm.nih.gov/pubmed/13347482


PMID: 13347482 Owner: NLM Status: MEDLINE
Abstract/OtherAbstract:
Authors: T M FEINBLATT; H M FEINBLATT; E A FERGUSON
Publication Detail: Type: Journal Article
Journal Detail: Title: Medical times Volume: 84 ISSN: 0025-7583 ISO Abbreviation: Med Times Publication Date: 1956 Jul
Date Detail: Created Date: 1956-12-01 Completed Date: 2003-05-01 Revised Date: 2006-11-15
Medline Journal Info: Nlm Unique ID: 0406055 Medline TA: Med Times Country: Not Available
Other Details: Languages: eng Pagination: 741-3 Citation Subset: OM

Pub med id 13347482

Med Times. 1956 Jul;84(7):741-3.

Arteriosclerotic syndromes; niacinamide hydroiodide (parenteral) treatment.

FEINBLATT TM, FEINBLATT HM, FERGUSON EA Jr.

PMID: 13347482 [PubMed - indexed for MEDLINE]

T M FEINBLATT, H M FEINBLATT, E A FERGUSON
Med Times
Jul 1956 (Vol. 84, Issue 7,Pages 741-3)
Arteriosclerotic syndromes; niacinamide hydroiodide (parenteral) treatment.
FEINBLATT TM, FEINBLATT HM, FERGUSON EA Jr.
PMID:13347482
[PubMed - indexed for MEDLINE]
Minerva Med. 1957 Oct 24;48(85):3544-8.
[Nicotinamide hydroiodide in the treatment of degenerative arterial diseases].
[Article in Italian]
GUAGLIANO G, STOPPANI L.

13493209
[PubMed - indexed for MEDLINE]

Med Times. 1956 Jul;84(7):741-3.
Arteriosclerotic syndromes; niacinamide hydroiodide (parenteral) treatment.
FEINBLATT TM, FEINBLATT HM, FERGUSON EA Jr.
PMID:
13347482
[PubMed - indexed for MEDLINE]
ABRAHAMSON IA Sr, ABRAHAMSON IA Jr.
Am J Ophthalmol. 1956 Nov;42(5):771-2. No abstract available.
PMID:
13372702
[PubMed - OLDMEDLINE]
Related citations
http://floatertalk.yuku.com/topic/3988

Use of iodo-niacin for retinal or vitreous hemorrhages and vitreous floaters.
November 1956 Am J Ophthalmol Vol. 42, Issue 5, Pages 771-2

Use of Iodo-Niacin, Abrahamson, I. A.: American Journal of Ophthalmology 42 (5): 771-772 1956
http://web.archive.org/web/20070908193524/http:/panaminstitute.com/de-iodine.htm


Perhaps someone can find the published XRAYS of the before and after, AFTER treatment. Thanks.

t2t







 

<< Return to the standard message view

fetched in 0.05 sec, referred by http://www.curezone.org/forums/fmp.asp?i=1970526